Dr. Mariko Sato, MD, PhD
- Publications
- 17
- Clinical trials
- 10
- Industry payments
- $21,233
- State licenses
- 3
- Year NPI issued
- 2008
- Practice address
- 1201 W La Veta Ave, Orange, CA 92868
- Practice phone
- Call (714) 997-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Children's Hospital of Orange County Main Campus
Orange, California
Find Dr. Sato's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mariko Sato is a pediatric hematology and oncology physician in Orange, California
Dr. Sato practices at Children's Hospital of Orange County Main Campus in Orange, California.
Dr. Sato's NPI, 1326207978, was assigned on June 7, 2008. Dr. Sato holds Iowa license MD-42075.
- NPI
- 1326207978NPI Registry (opens in a new tab)
- NPI enumeration date
- June 7, 2008
- NPI status
- Active
- Practice phone
- (714) 997-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Mariko Sato practices at Children's Hospital of Orange County Main Campus in Orange, California
Dr. Sato's primary practice is Children's Hospital of Orange County Main Campus, at 1201 W La Veta Ave, Orange, CA 92868 in Orange County. The practice phone is (714) 997-3000.
- Children's Hospital of Orange County Main Campus1201 W La Veta Ave, Orange, CA 92868 · Orange CountyPhone(714) 997-3000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mariko Sato is affiliated with 1 site of care
Dr. Sato's primary practice is Children's Hospital of Orange County Main Campus in Orange, California.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Mariko Sato's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sato practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Children's Hospital of Orange County Main Campus | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mariko Sato is one of 385 pediatric hematologys and oncology physicians in California
Pediatric hematology-oncology is Dr. Sato's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Sato's licenses on file in 3 states: Iowa, California and Utah.
Specialties and state licenses
- Pediatric hematology and oncology, IowaPrimary
- California license
- Pediatrics, Utah
Pediatric hematologys and oncology physicians near Dr. Sato
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mariko Sato's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. Sato's median patient age at 13, with 44% women.
Dr. Sato's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women44%
- Men55%
Source: Dmand AI Patient Panel Data
Dr. Mariko Sato has 17 publications on record
Dmand AI links 17 papers to Dr. Sato, published from 2015 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Brain Neoplasms, Glioma and Brain. Dr. Sato has published most often in Pediatr Blood Cancer. Dr. Sato's most frequent co-authors are John Ross Crawford, MD, Michael Gregory Brandel, MD and Murali Chintagumpala, MD.
Dr. Sato's papers by year, 2015 to 2025
Topics Dr. Sato writes about most
- Brain Neoplasms
- Glioma
- Brain
- Central Nervous System Neoplasms
- Magnetic Resonance Imaging
Dr. Sato's most frequent co-authors
- John Ross Crawford, MD6 shared papers
- Michael Gregory Brandel, MD2 shared papers
- Murali Chintagumpala, MD2 shared papers
Recent publications by Dr. Sato
See who Dr. Sato researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sato works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mariko Sato has worked on 10 clinical trials
Dmand AI links Dr. Sato to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Central Nervous System Neoplasms, Down Syndrome and Hodgkin Disease. Children's Oncology Group sponsors the most, 5.
Clinical trials with Dr. Sato by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Sato's trials
- Central Nervous System Neoplasms
- Down Syndrome
- Hodgkin Disease
- Leukemia, Myeloid, Acute
- Medulloblastoma
Investigators on the most trials with Dr. Sato
- Phillip Evan Barnette10 shared trials
- John J. Gregory, MD9 shared trials
- Timothy Cameron Griffin, MD9 shared trials
Recent clinical trials with Dr. Sato
A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations (opens in a new tab)
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (opens in a new tab)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (opens in a new tab)
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mariko Sato received $21,233 in industry payments from 2018 to 2025
CMS Open Payments shows 34 general payments to Dr. Sato from 11 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 94% of the total. Alexion Pharmaceuticals, Inc. paid the most, $14,875.
General payments to Dr. Sato by program year, 2018 to 2025
General payments to Dr. Sato by kind, 2018 to 2025
- Consulting fees$19,90094%
- Food and beverage$1,0185%
- Travel and lodging$3151%
Companies that paid Dr. Sato the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Mariko Sato's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mariko Sato
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mariko Sato's NPI number?
Dr. Mariko Sato's NPI number is 1326207978. It was assigned on June 7, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Mariko Sato?
Dr. Mariko Sato is a pediatric hematology and oncology physician in Orange, California. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Mariko Sato practice?
Dr. Sato practices at 1201 W La Veta Ave, Orange, CA 92868. Dr. Sato's primary practice is Children's Hospital of Orange County Main Campus in Orange, California.
What is Dr. Mariko Sato's office phone number?
The practice phone on file for Dr. Sato is (714) 997-3000.
What is Dr. Mariko Sato's medical license number?
Dr. Sato holds Iowa license MD-42075, one of the licenses on file in 3 states.
Which states has Dr. Mariko Sato been licensed in?
Dmand AI has state licenses on file for Dr. Sato in Iowa, California and Utah.
Has Dr. Mariko Sato received payments from drug or device companies?
CMS Open Payments shows $21,233 in general payments to Dr. Sato from 11 companies from 2018 to 2025. The largest total came from Alexion Pharmaceuticals, Inc.
How long has Dr. Mariko Sato been practicing?
Dr. Sato's NPI was assigned in 2008.
Does Dr. Mariko Sato do research?
Dmand AI links 17 publications to Dr. Sato, published from 2015 to 2025. Dr. Sato has worked on 10 clinical trials.
Who does Dr. Mariko Sato publish with?
Dr. Sato's most frequent co-authors are John Ross Crawford, MD (6 shared papers), Michael Gregory Brandel, MD (2 shared papers) and Murali Chintagumpala, MD (2 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card